Guangzhou Baiyunshan Pharmaceutical Holdings Co (SHSE:600332) Cyclically Adjusted Book per Share: ¥17.78 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600332 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd SHSE:600332
71 GF Score
Price ¥22.66
GF Value ¥29.44
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Cyclically Adjusted Book per Share?

Guangzhou Baiyunshan Pharmaceutical Holdings Co SHSE:600332 +0.98% 71 Cyclically Adjusted Book per Share is ¥17.78 as of Mar. 2026. GuruFocus rates SHSE:600332 with a GF Score™ of 71/100 and a GF Value™ of ¥29.44 (Modestly Undervalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Guangzhou Baiyunshan Pharmaceutical Holdings Co's adjusted book value per share for the three months ended in Mar. 2026 was ¥24.333. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥17.78 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Guangzhou Baiyunshan Pharmaceutical Holdings Co's average Cyclically Adjusted Book Growth Rate was 11.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 11.50% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 12.30% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 13.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Guangzhou Baiyunshan Pharmaceutical Holdings Co was 15.20% per year. The lowest was 5.20% per year. And the median was 12.20% per year.

As of today (2026-07-16), Guangzhou Baiyunshan Pharmaceutical Holdings Co's current stock price is ¥22.66. Guangzhou Baiyunshan Pharmaceutical Holdings Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ¥17.78. Guangzhou Baiyunshan Pharmaceutical Holdings Co's Cyclically Adjusted PB Ratio of today is 1.27.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Guangzhou Baiyunshan Pharmaceutical Holdings Co was 6.45. The lowest was 1.11. And the median was 2.97.


Guangzhou Baiyunshan Pharmaceutical Holdings Co  (SHSE:600332) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Guangzhou Baiyunshan Pharmaceutical Holdings Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=22.66/17.78
=1.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Guangzhou Baiyunshan Pharmaceutical Holdings Co was 6.45. The lowest was 1.11. And the median was 2.97.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Guangzhou Baiyunshan Pharmaceutical Holdings Co Cyclically Adjusted Book per Share Related Terms


Guangzhou Baiyunshan Pharmaceutical Holdings Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Guangzhou Baiyunshan Pharmaceutical Holdings Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Cyclically Adjusted Book per Share Chart

Guangzhou Baiyunshan Pharmaceutical Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.02 12.48 13.99 15.57 17.30

Guangzhou Baiyunshan Pharmaceutical Holdings Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.00 16.37 16.85 17.30 17.78

SHSE:600332 vs MCK, CAH, COR: Cyclically Adjusted Book per Share Comparison

For the Medical Distribution subindustry, Guangzhou Baiyunshan Pharmaceutical Holdings Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guangzhou Baiyunshan Pharmaceutical Holdings Co Cyclically Adjusted PB Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Guangzhou Baiyunshan Pharmaceutical Holdings Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Guangzhou Baiyunshan Pharmaceutical Holdings Co's Cyclically Adjusted PB Ratio falls into.


SHSE:600332
71GF Score
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd SHSE:600332
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guangzhou Baiyunshan Pharmaceutical Holdings Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Guangzhou Baiyunshan Pharmaceutical Holdings Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=24.333/116.3033*116.3033
=24.333

Current CPI (Mar. 2026) = 116.3033.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Quarterly Data

Book Value per Share CPI Adj_Book
201606 7.197 101.400 8.255
201609 10.692 102.400 12.144
201612 10.669 102.600 12.094
201703 10.969 103.200 12.362
201706 11.101 103.100 12.523
201709 11.301 104.100 12.626
201712 11.605 104.500 12.916
201803 12.163 105.300 13.434
201806 12.837 104.900 14.232
201809 13.338 106.600 14.552
201812 13.338 106.500 14.566
201903 14.204 107.700 15.339
201906 14.480 107.700 15.637
201909 14.858 109.800 15.738
201912 14.876 111.200 15.559
202003 15.607 112.300 16.163
202006 15.372 110.400 16.194
202009 15.914 111.700 16.570
202012 16.081 111.500 16.774
202103 17.080 112.662 17.632
202106 17.080 111.769 17.773
202109 17.579 112.215 18.219
202112 17.876 113.108 18.381
202203 18.986 114.335 19.313
202206 18.785 114.558 19.071
202209 19.331 115.339 19.493
202212 19.723 115.116 19.926
202303 20.893 115.116 21.109
202306 20.720 114.558 21.036
202309 21.319 115.339 21.497
202312 21.478 114.781 21.763
202403 22.683 115.227 22.895
202406 22.305 114.781 22.601
202409 22.280 115.785 22.380
202412 22.084 114.893 22.355
202503 23.200 115.116 23.439
202506 23.226 114.907 23.508
202509 23.316 115.471 23.484
202512 23.243 115.832 23.338
202603 24.333 116.303 24.333

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ¥17.78 mean?
Guangzhou Baiyunshan Pharmaceutical Holdings Co (SHSE:600332) has a Cyclically Adjusted Book per Share of ¥17.78 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Guangzhou Baiyunshan Pharmaceutical Holdings Co and its competitors.
Is Guangzhou Baiyunshan Pharmaceutical Holdings Co's Cyclically Adjusted Book per Share too high?
Guangzhou Baiyunshan Pharmaceutical Holdings Co's current Cyclically Adjusted Book per Share is ¥17.78. Overall, Guangzhou Baiyunshan Pharmaceutical Holdings Co has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Guangzhou Baiyunshan Pharmaceutical Holdings Co's Cyclically Adjusted Book per Share compare to MCK and CAH?
Guangzhou Baiyunshan Pharmaceutical Holdings Co's Cyclically Adjusted Book per Share of ¥17.78 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Distribution company?
A good Cyclically Adjusted Book per Share depends on the Medical Distribution industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Guangzhou Baiyunshan Pharmaceutical Holdings Co and its competitors. Guangzhou Baiyunshan Pharmaceutical Holdings Co's current Cyclically Adjusted Book per Share is ¥17.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangzhou Baiyunshan Pharmaceutical Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Guangzhou Baiyunshan Pharmaceutical Holdings Co (SHSE:600332) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥29.44, compared to a current price of ¥22.66 — trading 23% below its estimated fair value. The current Cyclically Adjusted Book per Share is ¥17.78. Guangzhou Baiyunshan Pharmaceutical Holdings Co's overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Guangzhou Baiyunshan Pharmaceutical Holdings Co (SHSE:600332), the current Cyclically Adjusted Book per Share is ¥17.78 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guangzhou Baiyunshan Pharmaceutical Holdings Co (SHSE:600332) Overvalued in 2026?

Based on GuruFocus' analysis, Guangzhou Baiyunshan Pharmaceutical Holdings Co stock appears to be undervalued. The current stock price of ¥22.66 is trading 23% below its estimated GF Value™ of ¥29.44. GuruFocus considers Guangzhou Baiyunshan Pharmaceutical Holdings Co to be Modestly Undervalued.

Key valuation signals for SHSE:600332:

  • Cyclically Adjusted Book per Share: ¥17.78
  • GF Value™: ¥29.44 vs. price of ¥22.66 (23% below fair value)
  • GF Score™: 71/100 with 6 warning signs

No single metric tells the full story. See the SHSE:600332 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Guangzhou Baiyunshan Pharmaceutical Holdings Co Business Description

Other Exchanges 00874:Hong KongGU5:Germany
Address 45 Sha Mian North Street, Liwan District, Guangdong Province, Guangzhou, CHN, 510130
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is engaged in the pharmaceutical and healthcare industry, focusing on the development of a full industrial chain covering research, manufacturing, and distribution. The group operates through five reportable segments. The Modern Chinese Medicine segment involves the R&D, manufacturing, and sale of proprietary Chinese and natural medicines. The Chemical Pharmaceutical Technology segment focuses on chemical drugs, APIs, and intermediates. The Natural Beverages segment produces and sells health-oriented beverage products. The Pharmaceutical Commerce segment is engaged in the wholesale, retail, and import/export of medicines and medical devices. The Other Segments include biotechnology innovation, consumer health, and medical services.
71GF Score

Get the complete analysis for SHSE:600332

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥22.66
Price
¥29.44
GF Value